STAT activation subsequently up-regulates anti-apoptotic proteins MCL-1 and BCL-xL, increases cell survival and confers CLL resistance to cytotoxic agents. This evidence concerns the gene BCL2L1 and B-cell chronic lymphocytic leukemia.